Ascendis Pharma A/S (ASND) Ownership

$216.32

$1.78 (-0.82%)
Last update: 05:56 AM EST
Day's range
$213.02
Day's range
$221.8

Ascendis Pharma A/S Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
WESTFIELD CAPITAL MANAGEMENT CO LP 02/11/2026 5.19 M $1.11 B   -1.41% 8.50%
CAPITAL INTERNATIONAL INVESTORS 02/11/2026 3.06 M $653.36 M   0.11% 5.02%
FRANKLIN RESOURCES INC 02/11/2026 1.91 M $407.31 M   20.13% 3.13%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 01/22/2026 1.89 M $402.25 M   0.19% 3.09%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 1.03 M $218.87 M   29.32% 1.68%
MORGAN STANLEY 02/13/2026 617.97 K $131.78 M   51.92% 1.01%
GOLDMAN SACHS GROUP INC 02/10/2026 596.70 K $127.24 M   -8.62% 0.98%
JPMORGAN CHASE & CO 02/11/2026 507.24 K $108.16 M   73.48% 0.83%
UBS GROUP AG 01/29/2026 308.19 K $65.72 M   57.88% 0.51%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 307.09 K $65.48 M   28.74% 0.50%
DEUTSCHE BANK AG\ 02/11/2026 296.82 K $63.29 M   326.71% 0.49%
SEI INVESTMENTS CO 02/13/2026 281.47 K $60.02 M   37.09% 0.46%
TD ASSET MANAGEMENT INC 02/10/2026 234.01 K $49.90 M   -21.03% 0.38%
ABRDN PLC 01/16/2026 221.68 K $47.27 M   348.50% 0.36%
BANK OF NEW YORK MELLON CORP 02/10/2026 194.61 K $41.50 M   -7.02% 0.32%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/15/2026 187.64 K $40.02 M   -2.10% 0.31%
NEW YORK STATE COMMON RETIREMENT FUND 02/12/2026 182.23 K $38.86 M   7.26% 0.30%
ARS INVESTMENT PARTNERS, LLC 02/05/2026 174.61 K $37.23 M   -0.60% 0.29%
BRAUN STACEY ASSOCIATES INC 01/20/2026 119.10 K $25.40 M   26.77% 0.20%
IMC-CHICAGO, LLC 01/29/2026 113.68 K $24.24 M   100.00% 0.19%
CITIGROUP INC 02/13/2026 75.90 K $16.18 M   100.00% 0.12%
JANE STREET GROUP, LLC 02/12/2026 73.60 K $15.69 M   0.00% 0.12%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 73.42 K $15.49 M   -4.72% 0.12%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 68.86 K $14.68 M   1.19% 0.11%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 57.08 K $12.17 M   -22.03% 0.09%
NOMURA ASSET MANAGEMENT CO LTD 02/10/2026 43.70 K $9.32 M   57.48% 0.07%
DIVERSIFIED TRUST CO 01/09/2026 42.25 K $9.01 M   -7.51% 0.07%
EMPOWERED FUNDS, LLC 02/11/2026 36.70 K $7.83 M   1.72% 0.06%
WELLS FARGO & COMPANY/MN 02/13/2026 33.78 K $7.20 M   6.66% 0.06%
CITIGROUP INC 02/13/2026 30.84 K $6.58 M   38.24% 0.05%
DEKABANK DEUTSCHE GIROZENTRALE 01/28/2026 30.00 K $4.84 M   0.00% 0.05%
MATISSE CAPITAL 01/29/2026 27.31 K $5.82 M   4.94% 0.04%
CAPITAL INTERNATIONAL SARL 02/11/2026 24.94 K $5.32 M   -19.18% 0.04%
STERLING CAPITAL MANAGEMENT LLC 02/13/2026 24.81 K $5.29 M   0.10% 0.04%
HARBOR CAPITAL ADVISORS, INC. 01/20/2026 22.73 K $4.85 M   -1.17% 0.04%
WALLEYE TRADING LLC 02/13/2026 21.90 K $4.67 M   32.73% 0.04%
JANE STREET GROUP, LLC 02/12/2026 21.23 K $4.53 M   100.00% 0.03%
ERSTE ASSET MANAGEMENT GMBH 02/11/2026 20.30 K $4.28 M   0.00% 0.03%
STIFEL FINANCIAL CORP 02/13/2026 20.20 K $4.31 M   -0.86% 0.03%
CITIGROUP INC 02/13/2026 20.00 K $4.26 M   100.00% 0.03%
CAPITAL INTERNATIONAL LTD /CA/ 02/11/2026 16.86 K $3.60 M   -22.20% 0.03%
ENVESTNET ASSET MANAGEMENT INC 02/10/2026 16.34 K $3.48 M   -34.55% 0.03%
SECTOR GAMMA AS 02/12/2026 16.31 K $3.48 M   -32.98% 0.03%
CALAMOS ADVISORS LLC 01/29/2026 16.30 K $3.48 M   152.71% 0.03%
ZWEIG-DIMENNA ASSOCIATES LLC 02/10/2026 15.50 K $3.31 M   100.00% 0.03%
LEGAL & GENERAL GROUP PLC 02/09/2026 14.78 K $3.15 M   938.13% 0.02%
HANDELSBANKEN FONDER AB 02/06/2026 14.27 K $3.04 M   5.16% 0.02%
LPL FINANCIAL LLC 02/11/2026 14.13 K $3.01 M   43.40% 0.02%
BARCLAYS PLC 02/13/2026 11.24 K $2.40 M   4.28% 0.02%
SG AMERICAS SECURITIES, LLC 01/09/2026 11.21 K $2.39 M   319.96% 0.02%

Ascendis Pharma A/S institutional Ownership - FAQ's

During the previous two years, 305 institutional investors and hedge funds held shares of Ascendis Pharma A/S. The most heavily invested institutionals were:

WESTFIELD CAPITAL MANAGEMENT CO LP: 5.19 M

Capital International Investors: 3.06 M

FRANKLIN RESOURCES INC: 1.91 M

MASSACHUSETTS FINANCIAL SERVICES CO /MA/: 1.89 M

PRINCIPAL FINANCIAL GROUP INC: 1.03 M

MORGAN STANLEY: 617,968

37.10% of Ascendis Pharma A/S stock is owned by institutional investors.

Institutional investors have bought a total of 69.84 M shares in the last 24 months. This purchase volume represents approximately $15.11 B in transactions.